NEW PATENTS, RELATED TO COVID 19

 

NEW PATENTS

1 WO/2021/258625ANTI-SAR-COV-2 (COVID-19) FULLY HUMANIZED MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES

2 WO/2021/260164THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONS

IN2CURE AB

3 WO/2021/211332METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-Β-CORONAVIRUS ANTIBODY IN A SAMPLE

ABBOTT LABORATORIES

4  WO/2021/262744KITS AND METHODS FOR ISOTHERMALLY AMPLIFYING RIBONUCLEIC ACID OF SEVERE ACUTE RESPIRATORY VIRUS COV2

UNIVERSITY OF WASHINGTON

5 WO/2021/262894METHODS FOR DIAGNOSING RESPIRATORY PATHOGENS AND PREDICTING COVID-19 RELATED OUTCOMES

THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

////////////////

APRIL 2018 New patents

APRIL 2018

New patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03305769	ROXADUSTAT	ZENTIVA	ANEMIA
2	EP-03305799	OBETICHOLIC ACID	LUPIN	P rimary biliary cirrhosis
3	WO-2018067945	VALBENAZINE	ASSIA TEVA	Huntingtons chorea; Tardive dyskinesia; Tourette syndrome
4	WO-2018067805	SOTAGLIFLOZIN	TEVA	Diabetes mellitus
5	WO-2018066004	DORZOLAMIDE	INDOCO	Glaucoma; Ocular hypertension
6	WO-2018065999	PALBOCICLIB	MYLAN	Breast tumor
7	WO-2018065924	BINIMETINIB SELUMETINIB	SUN	Cancer; Melanoma
8	WO-2018064797	ACALABRUTINIB	SOLIPHARMA	Autoimmune disease; Inflammatory disease; Lymphoma
9

 ,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018064585	ODALASVIR	ACHILLION	Hepatitis C virus infection
2	WO-2018062799	ASIVATREP	AMOREPACIFIC	Asthma; Chronic obstructive pulmonary disease; Dermatological disease; Inflammatory bowel disease; Inflammatory disease; Irritable bowel syndrome
3	WO-2018061034	APREMILAST	SUN	Arthritis
4	WO-2018060916	BREXPIPRAZOLE	ALEMBIC	Major depressive disorder; Schizophrenia
5	WO-2018060781	LACOSAMIDE	UNICHEM	Epilepsy; Partial seizure
6	WO-2018059914	GADOBUTROL	BAYER	Artery disease; Brain tumor; Breast tumor; Central nervous system disease; Vascular disease
7	WO-2018059556	VOROLANIB	BETTA	Gastrointestinal stromal tumor; Renal cell carcinoma
8	WO-2018059531	TOZADENANT	CRYSTAL	Alzheimers disease; Anxiety disorder; Attention deficit hyperactivity disorder; Depression; Huntingtons chorea; Parkinsons disease; Schizophrenia
9	WO-2018059288	MACITENTAN	SEASONS	Idiopathic pulmonary arterial hypertension
10	WO-2018058296	AZELIRAGON	SOLIPHARMA	Alzheimers disease

NEW PATENTS FEB 2018

New patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018033631	MARIZOMIB	CELGENE	CANCER
2	WO-2018034901	ELAMIPRETIDE	STEALTH	Barth syndrome; Mitochondrial myopathy
3	WO-2018033866	SACUBITRIL, VALSARTAN	NOVARTIS	CARDIAC FAILURE, HYPERTENSION
4	WO-2018033149	OZANIMOD	CRYSTAL	Multiple sclerosis; Ulcerative colitis
5	WO-2018033139	SOFOSBUVIR	CHIA	Hepatitis C virus infection
6	WO-2018032521	LIRAGLUTIDE	SHENZEN	Non-insulin dependent diabetes; Obesity
7	WO-2018032356	SOFOSBUVIR	PHARMARESOURCES	Hepatitis C virus infection
8	WO-2018032796	SITAFLOXACIN	CHEN-STONE	Bacterial infection
9	WO-2018033939	BUDESONIDE	ANANTCO	Allergic rhinitis; Inflammatory bowel disease; Irritable bowel syndrome

 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03281941	LESINURAD	ZENTIVA	Gout; Hyperuricemia
2	WO-2018029711	VENETOCLAX	MYLAN	Chronic lymphocytic leukemia
3	WO-2018029699	BELINIOSTAT	MSN	Hematological neoplasm; Solid tumor
4	WO-2018029264	DAPAGLIFLOZIN	AMNEAL	Non-insulin dependent diabetes
5	WO-2018029223	GALETERONE	INDUSTRIALE	PROSTRATE TUMOR
6	WO-2018028508	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
7	WO-2018028506	PIRFENIDONE	IND	Idiopathic pulmonary fibrosis
8	WO-2018029611	DAPAGLIFLOZIN	LAURUS	Non-insulin dependent diabetes
9	WO-2018028420	PLINABULIN	QUINGDAO	CANCER
10	WO-2018028679	MIRABEGRON	ZHEJIANG	Overactive bladder